Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes

• Main Authors: Arie, T.B.B (Author), Drágus, E. (Author), Fülöp, Z. (Author), Gángó, A. (Author), Kovács, K.A (Author), Kulka, J. (Author), Pesti, A. (Author), Pipek, O. (Author), Rusz, O. (Author), Szász, A.M (Author), Szeitz, B. (Author), Szundi, C. (Author), Tőkés, A.M (Author), Tőkés, T. (Author), Vári-Kakas, S.A (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: breast carcinoma subtypes; CD4+ T cells; CD8+ T cells; immune-related gene; NanoString; TIL
• Online Access: View Fulltext in Publisher

 We hypothesized that different BC subtypes are characterized by spatially distinct tumor immune microenvironment (TIME) and that immune gene assembly of metastatic (Met) and non-metastatic (Ctrl) BCs vary across subtypes. Peritumoral, stromal and intratumoral TIL was assessed on 309 BC cases. Hot, cold and immune-excluded groups were defined, and the prognostic role of this classification was assessed. CD4+ /CD8+ positivity was analyzed in 75 cases in four systematically predefined tumor regions. Immune gene expression of Met and Ctrl HER2-negative BCs was compared by using NanoString nCounter technology. The amount of TIL infiltration varied greatly within all BC subtypes. Two-third of the cases were cold tumors with no significant survival difference compared to hot tumors. A lower CD4+ /CD8+ ratio at the stromal internal tumor region was significantly associated with longer distant metastasis-free survival. The differentially expressed immune genes between Met and Ctrl varied across the studied BC subtypes with TNBC showing distinct features from the luminal subtypes. The TIME is characterized by a considerable heterogeneity; however, low level of TILs does not equate to disease progression. The differences in immune gene expression observed between Met and Ctrl breast carcinomas call attention to the important role of altered immune function in BC progression. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.